Updated on 3 May 2012
Raising concerns, the statement by the biotech industry forum says, "This is a question that will come up for considerable debate as to whether it is really a true life-saving classification. In future before such rulings are invoked, it might be a good idea to debate on the cost of goods versus the cost of innovation. If we put in mechanisms to compensate the companies which do innovation, then the severity of such rulings will be quite considerably mitigated."
ABLE expressed its concerns by pointing out that the momentum and global image of India's focus on innovation might be at risk, at a time when the Indian government has declared this as the Decade of Innovation.